Fiduciary Trust Co Buys 311 Shares of CME Group Inc. (NASDAQ:CME)

Fiduciary Trust Co grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 11.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,143 shares of the financial services provider’s stock after buying an additional 311 shares during the period. Fiduciary Trust Co’s holdings in CME Group were worth $730,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. Wealth Enhancement Advisory Services LLC raised its position in shares of CME Group by 0.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 61,934 shares of the financial services provider’s stock worth $13,666,000 after purchasing an additional 168 shares during the period. Harbor Capital Advisors Inc. raised its position in CME Group by 2.6% in the 4th quarter. Harbor Capital Advisors Inc. now owns 8,013 shares of the financial services provider’s stock valued at $1,861,000 after buying an additional 203 shares during the last quarter. Graypoint LLC raised its position in CME Group by 14.3% in the 4th quarter. Graypoint LLC now owns 2,877 shares of the financial services provider’s stock valued at $668,000 after buying an additional 359 shares during the last quarter. Czech National Bank raised its position in CME Group by 6.5% in the 4th quarter. Czech National Bank now owns 78,133 shares of the financial services provider’s stock valued at $18,145,000 after buying an additional 4,778 shares during the last quarter. Finally, Fiduciary Alliance LLC raised its position in CME Group by 17.9% in the 4th quarter. Fiduciary Alliance LLC now owns 23,485 shares of the financial services provider’s stock valued at $5,454,000 after buying an additional 3,571 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent research reports. Oppenheimer lifted their target price on CME Group from $269.00 to $279.00 and gave the company an “outperform” rating in a research report on Friday, April 11th. Barclays lifted their target price on CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 23rd. Piper Sandler lifted their target price on CME Group from $275.00 to $283.00 and gave the company an “overweight” rating in a research report on Tuesday, April 8th. Morgan Stanley boosted their price target on CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research report on Thursday, April 24th. Finally, Bank of America boosted their price target on CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average price target of $256.80.

Insider Transactions at CME Group

In related news, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. The trade was a 12.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This trade represents a 34.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 34,726 shares of company stock worth $8,975,813. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of NASDAQ CME opened at $284.35 on Monday. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $287.36. The stock has a 50 day moving average of $264.47 and a 200-day moving average of $245.78. The company has a market capitalization of $102.47 billion, a P/E ratio of 29.41, a P/E/G ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the company posted $2.50 EPS. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.76%. CME Group’s dividend payout ratio is currently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.